ArticleFrontiers in genetics2022
Exploring prognostic indicators in the pathological images of ovarian cancer based on a deep survival network.
Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparing the Effectiveness of Artificial Intelligence Models in Predicting Ovarian Cancer Survival: A Systematic Review.Cancer reports (Hoboken, N.J.) · 2025Pooled it
- Risk prediction model of survival in patients with low-grade serous ovarian cancer: a multicenter Cohort study.Journal of ovarian research · 2026Article
- Pathological omics prediction of early and advanced colon cancer based on artificial intelligence model.Discover oncology · 2025Article
- Construction of prognostic scoring model for ovarian cancer based on deep learning algorithm.Discover oncology · 2025Article
- An enhanced deep learning model for accurate classification of ovarian cancer from histopathological images.Scientific reports · 2025Article
- Review
- Predicting the Evolution of Lung Squamous Cell Carcinoma In Situ Using Computational Pathology.Bioengineering (Basel, Switzerland) · 2025Article
- Review
- Explainable AI-based feature importance analysis for ovarian cancer classification with ensemble methods.Frontiers in public health · 2025Article
- Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).Oncology reports · 2024Review
- Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches.Frontiers in oncology · 2024Review
- Article
- Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer.Translational oncology · 2023Article
- Artificial intelligence in ovarian cancer histopathology: a systematic review.NPJ precision oncology · 2023Review
- Recent Advancements in Deep Learning Using Whole Slide Imaging for Cancer Prognosis.Bioengineering (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.